IRCT20130418013058N12 IRCT 2019-05-18 Mashhad University of Medical Sciences Effect of crocin on ocular complications of Behcet's disease Pilot Study on the effectiveness of crocin as a drug supplement in the treatment of ocular complications of Behcet's disease; a clinical trial 2019-02-19 anticipated 40 Complete https://irct.ir/trial/36998 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: For each tablet container, four-digit codes will be Randomly labeled to Each Box by pharmacist . The Therapist will give it to the Patient Randomly without Knowledge of the Type of Medicine. Thus, the nature of each code will not be known until the analysis of the results, Blinding description: Crocin and placebo tablets will be prepared in a similar shape, color, and size, stored in a dark container and coded by a pharmacist. The physician, researcher and patients will not be aware of the code printed on the container. 2-3 Behcet's Disease. Intervention 1: Intervention group: Receiving one tablet of Crocin (15 mg) for three months. Intervention 2: Control group: Receiving one tablet of placebo for three months. No - There is not a plan to make this available Justification or reason for not sharing IPD is As regards to that the work has not begun, a definitive decision on this information has not yet been taken.